@xconomy.com 5 months ago
Bio Roundup: Fast FDA Approvals, Biogen Delays, ORIC’s IPO & More
@xconomy.com 1 year ago
Synthorx Files for IPO to Advance Enhanced Cytokine Drugs
@xconomy.com 2 years ago
Synthorx Raises $63M to Advance Suite of Enhanced Cytokine Drugs